The Federation of Indian Chambers of Commerce and Industry (FICCI), under the technical guidance of the Ministry of Health & ...

Thyrocare Technologies Limited, a leading healthcare diagnostics company in India, has launched a new diagnostic laboratory in Jamshedpur, Jharkhand, in collaboration with SecondMedic. Thyrocare has ...

Generic Remedy, the True MRP generic pharmacy brand operated by First Remedy Pharmacies Private Limited, has crossed 700+ ...

Akums Drugs & Pharmaceuticals announced the development of a DCGI-approved Clarithromycin + Vonoprazan + Amoxicillin Combikit for treating Helicobacter pylori (H. pylori) infection in adults. The ...

The U.S. Food and Drug Administration (FDA) has approved imlunestrant (Inluriyo) in combination with abemaciclib (Verzenio) for adults with estrogen receptor (ER)-positive, human epidermal growth ...

Scientists have created a detailed map of gene activity in the brain’s prefrontal cortex, providing new insights into normal brain development, ageing and major neurological and psychiatric disorders, ...

Renowned cardiologist and Padma Shri awardee Dr G Vijayaraghavan died in Thiruvananthapuram at the age of 84. He had been undergoing treatment for age-related health conditions. Dr Vijayaraghavan ...

The Ladakh administration has revised its guidelines for admission to MBBS and BDS seats under the Central Pool for the 2026–27 academic session. Under the new system, authorities will prepare […] ...

Ahead of World Heart Day 2026, the Illness to Wellness Foundation hosted a conference in New Delhi themed “Healthy Heart for a Healthy Life.” Cardiologists and healthcare experts discussed prevention, ...

Akums Drugs & Pharmaceuticals has developed a DCGI-approved triple therapy combikit to treat Helicobacter pylori (H. pylori) infection in adults. The treatment combines Clarithromycin 500 mg, ...

AI Takes Centre Stage in AYUSH The Ministry of Ayush is expanding the use of artificial intelligence (AI) across Ayurveda and ...

The government is considering amendments to the Medical Devices Rules, 2017, that could give regulators stronger powers to stop the manufacture, sale or distribution of unsafe, defective, substandard ...